Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy

Conclusions: IVC is a promising adjunctive treatment to PRP in the treatment of PDR. Single-dose IVC 1 week before PRP was suggested to improve PRP completion rate and patient satisfaction in the short term.Ophthalmologica

https://www.karger.com/Article/FullText/495423

Source: Ophthalmologica - January 31, 2019 Category: Opthalmology Source Type: research